Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Shares Sink 15 Percent After Second Analyst Downgrades Stock

NEW YORK, March 1 (GenomeWeb News) - Shares in Third Wave Technologies were down 15.08 percent, or $1.03, $5.80, in mid-morning trading after Piper Jaffray downgraded the stock to "Market Perform" from "Outperform."


The downgrade comes on the heels of a Feb. 23 downgrade from Cairns & Company, which demoted Third Wave stock to "Average" from "Above Average" following the company's disappointing fourth-quarter 2004 financial results.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.